Listen to The Lancet Respiratory Medicine

Adrian Martineau discusses his meta-analysis of individual patient data assessing whether vitamin D supplementation can help prevent asthma exacerbations.

Elissa Abrams discusses inhaled corticosteroids and wheeze in toddlers.

Mona Bafadhel discusses her work on using eosinophils as biomarkers in chronic obstructive pulmonary disease.

Valerie Page discusses the use of a statin, simvastatin, to help patients with delirium in the intensive care unit.

Daniele de Luca discusses his Position Paper, the first to provide a consensus definition of acute respiratory distress syndrome in neonates.

John Laffey discusses his geo-economic analysis of the LUNG SAFE study, and its implications for global clinical practice.

2017 marks the 50th anniversary of the first description of acute respiratory distress syndrome in a study published in The Lancet . To mark this, The Lancet Respiratory Medicine ’s June issue is themed around ARDS and critical care. Here, TLRM's Laura Feetham talks to Michael Matthay about recent advances in the field of ARDS.

Aaron van Dorn speaks with March for Science co-chair Jonathan Berman and march participant Elliott Haut, a trauma and critical care surgeon, about politics and science.

Andy Pavia discusses point of care testing for respiratory virus infection.

To mark World TB Day and the launch of a major new commission on drug-resistant tuberculosis, The Lancet Respiratory Medicine's  April issue is about TB. In this podcast, Aaron van Dorn interviews Stephen Gillespie about the special issue

Robert Hyzy talks to Laura Feetham about how to encourage critical care doctors to stop employing ineffective practices.

A look at the way COPD exacerbations are treated around the world. 

Simon Hart provides an overview of the January issue of The Lancet Respiratory Medicine, which focuses on idiopathic pulmonary fibrosis.

Melissa McDonnell discusses a new index used to predict mortality and disease outcomes for patients with bronchiectasis.

Marcelo Cypel discusses his findings on the use of ex-vivo lung perfusion in preserving transplantable lungs.

Christine Eulenburg discusses her study of the SERVE-HF trial.

Professor Wayne Hall talks about the challenge of reducing smoking in people with serious mental illness.

Professor Jane Davies discusses current trends in cystic fibrosis detection and treatment.

Donald Tashkin discusses a clinical trial for the treatment of scleroderma-related interstitial lung disease, a rare but devastating condition.

MeiLan Han discusses the highlights of the Commission with Luke Worley.

Dr. Theodore "Jack" Iwashyna discusses the differences between the treatment of patients with acute critical illness and persistent critical illness.

Dr. Dirkje Postma of the National Program of Lung Research discusses the changing face of pulmonary disease research.

Michael Kreuter discusses a pooled analysis of data on the role of antacid therapy in the progression of idiopathic pulmonary fibrosis.

Marius Hoeper and Patricia Lobo discuss the global burden of pulmonary hypertension, and options for treatment.

Jean-Louis Vincent discusses the changing clinical definition of sepsis.